These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2441633

  • 1. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G, Smith CI, Weissberg JI, Eisenberg M, Bissett J, Nair PV, Mastre B, Rosno S, Roskamp D, Waterman K.
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
    Lok AS, Novick DM, Karayiannis P, Dunk AA, Sherlock S, Thomas HC.
    Hepatology; 1985 Sep; 5(6):1132-8. PubMed ID: 2415436
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
    Perrillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC.
    Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
    Marcellin P, Ouzan D, Degos F, Brechot C, Metman EH, Degott C, Chevalier M, Berthelot P, Trepo C, Benhamou JP.
    Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
    Hoofnagle JH.
    J Hepatol; 1986 Sep; 3 Suppl 2():S73-80. PubMed ID: 2439579
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J.
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [Abstract] [Full Text] [Related]

  • 11. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
    Weller IV, Lok AS, Mindel A, Karayiannis P, Galpin S, Monjardino J, Sherlock S, Thomas HC.
    Gut; 1985 Jul; 26(7):745-51. PubMed ID: 2410328
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
    Weller IV, Bassendine MF, Craxi A, Fowler MJ, Monjardino J, Thomas HC, Sherlock S.
    Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
    Marcellin P, Pouteau M, Loriot MA, Boyer N, Degos F, Calès P, Bettan L, Bacq Y, Coppére H, Grange JD.
    Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
    Hoofnagle JH, Minuk GY, Dusheiko GM, Schafer DF, Johnson R, Straus S, Jones EA, Gerin JL, Ishak K.
    Hepatology; 1982 Mar; 2(6):784-8. PubMed ID: 6183183
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
    Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H.
    Nephrol Dial Transplant; 1994 Mar; 9(7):820-3. PubMed ID: 7526277
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.
    Fiume L, Cerenzia MR, Bonino F, Busi C, Mattioli A, Brunetto MR, Chiaberge E, Verme G.
    Lancet; 1988 Jul 02; 2(8601):13-5. PubMed ID: 2455204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.